March 17, 2017
Targovax ASA applies for transfer to Oslo Stock Exchange main list
Media
March 17, 2017
Cerenis Therapeutics announces that CARAT Phase 2 Study data on CER-001 have been presented at ACC annual meeting 2017
March 17, 2017
Nordic Nanovector announces first patient dosed in Phase 1 study of Betalutin® in diffuse large B-cell lymphoma (DLBCL), an aggressive form of NHL
March 15, 2017
Targovax ASA: Annual Report 2016
March 14, 2017
Strongbridge Biopharma plc to Present at the 27th Annual Oppenheimer Healthcare Conference and the 16th Annual Needham Healthcare Conference
March 13, 2017
MIPS announces its intention to list its shares on Nasdaq Stockholm
March 13, 2017
GenSight Biologics Reports Full Year 2016 Financial Results
March 08, 2017
Nexstim Plc announces signing of an Independent Selling Representative Agreement in the U.S. with Surgical Solutions, Inc.
March 07, 2017
Nexstim Plc Announces the Start of Patient Enrolment in the Supplementary Phase III Trial in Stroke Rehabilitation with its NBT system
March 06, 2017
NEXSTIM PLC PUBLISHES 2016 ANNUAL REPORT